Pharmacological effects in mice of anandamide and its related fatty acid ethanolamides, and enhancement of cataleptogenic effect of anandamide by phenylmethylsulfonyl fluoride

Biological and Pharmaceutical Bulletin

Volumn 22, Issue 4, 1999, Pages 366-370

  Watanabe, Kazuhito ^a   Matsunaga, Tamihide ^a   Nakamura, Shizuko ^a   Kimura, Toshiyuki ^a   Ho, Ing Kang ^b   Yoshimura, Hidetoshi ^c   Yamamoto, Ikuo ^a  

^a HOKURIKU UNIVERSITY   (Japan)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c NAKAMURA GAKUEN UNIVERSITY   (Japan)

Author keywords

Anandamide; Anandamide amidohydrolase; Catalepsy; Hypothermia; Phenylmethylsulfonyl fluoride; Sleep prolongation

Indexed keywords

ANANDAMIDE; ANANDAMIDE AMIDOHYDROLASE; BENZYLSULFONYL FLUORIDE; CANNABINOID; ETHANOLAMINE DERIVATIVE; N LINOLEOYLETHANOLAMINE; N MYRISTOYLETHANOLAMINE; N OLEOYLETHANOLAMINE; PALMIDROL; PENTOBARBITAL; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALEPSY; CONTROLLED STUDY; DRUG CLEARANCE; DRUG POTENTIATION; HYPOTHERMIA; LIVER MICROSOME; MALE; METABOLIC CLEARANCE RATE; MOUSE; NONHUMAN; SLEEP;

EID: 0032951351     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.22.366     Document Type: Article

References (33)

1. Devane W. A., Hanus L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R., Science, 258, 1946-1949 (1992).
2. Johnson D. E., Heald S. L., Dally R. D., Janis R. A., Prostaglandins Leukotriene Essential Fatty Acids, 48, 429-437 (1993).
3. Fride E., Mechoulam R., Eur. J. Pharmacol., 231, 313-314 (1993).
4. Pinto J. C., Potie F., Rice K. C., Boring D., Johnson M. R., Evans D. M., Wilken G. H., Cantrell C. H., Howlett A. C., Mol. Pharmacol, 46, 516-522 (1994).
5. Hillard C. J., Edgemond W. S., Campbell W. B., J. Neurochem., 64, 677-683 (1995).
6. Vogel Z., Barg J., Levy R., Saya D., Heldman E., Mechoulam R., J. Neurochem., 61, 352-355 (1993).
7. Felder C. C., Briley E. M., Axelrod J., Simpson J. T., Mackie K., Devane W. A., Proc. Natl. Acad. Sci. U.S.A., 90, 7656-7660 (1993).
8. Venance L., Piomelli D., Glowinski J., Giaume C., Nature (London), 376, 590-594 (1995).
9. Randall M. D., Alexander S. P. H., Bennett T., Boyd E. A., Fry J. R., Gandiner S M., Kemp R A., McCulloch A. I., Kendall D. A., Biochem. Biophys. Res. Commun., 229, 114-120 (1996).
10. Hanus L., Gopher A., Almog S., Mechoulam R., J. Med. Chem., 36, 3032-3034 (1993).
11. Pertwee R., Griffin G., Hanus L., Mechoulam R., Eur. J. Pharmacol., 259, 115-120 (1994).
12. Adams I. B., Ryan W., Singer M., Thomas B. F., Compton D. R., Razdan R. K., Martin B. R., J. Pharmacol. Exp. Ther., 273, 1172-1181 (1995).
13. Wise M. L., Soderstrom K., Murray T. F., Gerwick W. H., Experientia, 52, 88-92 (1996).
14. Facci L., Daltoso R., Romanello S., Buriani A., Skaper S. D., Leon A., Proc. Natl. Acad. Sci. U.S.A., 92, 3376-3380 (1995).
15. Deutsch D. G., Chin S. A., Biochem. Pharmacol., 46, 791-796 (1993).
16. Hillard C. J., Wilkinson D. M., Edgemond W. S., Campbell W. B., Biochim. Biophys. Acta, 1257, 249-256 (1995).
17. Ueda N., Kurahashi Y., Yamamoto S., Tokunaga T., J. Biol. Chem., 270, 23823-23827 (1995).
18. Smith P. B., Compton D. R., Welch S. P., Razdan R. K., Mechoulam R., Martin B. R., J. Pharmacol. Exp. Ther, 270, 219-227 (1994).
19. Willoughby K. A., Moore S. F., Martin B. R., Ellis E. F., J. Pharmacol. Exp. Ther., 282, 243-247 (1997).
20. Abadji V, Lin S., Taha G., Griffin G., Stevenson L. A., Pertwee R. G., Makriyannis A., J. Med. Chem., 37, 1889-1893 (1994).
21. Watanabe K., Ogi H., Nakamura S., Kayano Y., Matsunaga T, Yoshimura H., Yamamoto I., Life Sci., 62, 1223-1229 (1998).
22. Compton D. R., Martin B. R., J. Pharmacol. Exp. Ther., 283, 1138-1143 (1997).
23. Yoshimura H., Watanabe K., Oguri K., Fujiwara M., Ueki S., J. Med. Chem., 21, 1079-1080 (1978).
24. Litchfield J. T., Wilcoxon F., J. Pharmacol. Exp. Ther., 96, 99-113 (1949).
25. Watanabe K., Yamamoto I., Oguri K., Yoshimura H., Eur. J. Pharmacol.,63, 1-6 (1980).
26. Ueda N., Yamamoto K., Yamamoto S., Tokunaga T., Shirakawa E., Shinkai H., Ogawa M., Sato T. Kudo I., Inoue K., Takizawa H., Nagano T., Hirobe M., Matsuki N., Saito H., Biochim. Biophys. Acta, 1254, 127-134 (1995).
27. Watanabe K., Kayano Y., Matsunaga T., Yamamoto L, Yoshimura H., Biol. Pharm. Bull, 19, 1109-1111 (1996).
28. Watanabe K., Kijima T., Narimatsu S., Nishigami J., Yamamoto I., Yoshimura H., Chem. Pharm. Bull., 38, 2317-2319 (1990).
29. Thomas B. F., Adams I. B., Mascarella S. W., Martin B. R., Razdan R. K., J. Med. Chem., 39, 471-179 (1996).
30. Narimatsu S., Watanabe K., Yamamoto I., Yoshimura H., J. Pharmacobio-Dyn., 6, 558-564 (1983).
31. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N. E., Schatz A. R., Gopher A., Almog S., Martin B. R., Compton D. R., Pertwee R. G., Griffin G., Bayewitch M., Barg J., Vogel Z., Biochem. Pharmacol, 50, 83-90 (1995).
32. Yamamoto I., Watanabe K., Narimatsu S., Hamajima K., Yoshimura H. Eur. J. Pharmacol., 111, 159-166 (1985).
33. Crawley J. N., Corwin R. L., Robinson J. K., Felder C. C., Devane W. A., Axelrod J., Pharmacol. Biochem. Behav., 46, 967-972 (1993).